» Articles » PMID: 36569096

Nucleic Acid Testing of SARS-CoV-2: A Review of Current Methods, Challenges, and Prospects

Overview
Journal Front Microbiol
Specialty Microbiology
Date 2022 Dec 26
PMID 36569096
Authors
Affiliations
Soon will be listed here.
Abstract

Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and has brought a huge threat to public health and the global economy. Rapid identification and isolation of SARS-CoV-2-infected individuals are regarded as one of the most effective measures to control the pandemic. Because of its high sensitivity and specificity, nucleic acid testing has become the major method of SARS-CoV-2 detection. A deep understanding of different diagnosis methods for COVID-19 could help researchers make an optimal choice in detecting COVID-19 at different symptom stages. In this review, we summarize and evaluate the latest developments in current nucleic acid detection methods for SARS-CoV-2. In particular, we discuss biosensors and CRISPR-based diagnostic systems and their characteristics and challenges. Furthermore, the emerging COVID-19 variants and their impact on SARS-CoV-2 diagnosis are systematically introduced and discussed. Considering the disease dynamics, we also recommend optional diagnostic tests for different symptom stages. From sample preparation to results readout, we conclude by pointing out the pain points and future directions of COVID-19 detection.

Citing Articles

Strategic nucleic acid detection approaches for diagnosing African swine fever (ASF): navigating disease dynamics.

Zhu Y, Zhang M, Jie Z, Guo S, Zhu Z, Tao S Vet Res. 2024; 55(1):131.

PMID: 39375775 PMC: 11460097. DOI: 10.1186/s13567-024-01386-8.


Rapid, Portable, and Electricity-free Sample Extraction Method for Enhanced Molecular Diagnostics in Resource-Limited Settings.

Pennisi I, Cavuto M, Miglietta L, Malpartida-Cardenas K, Stringer O, Mantikas K Anal Chem. 2024; 96(28):11181-11188.

PMID: 38967089 PMC: 11256010. DOI: 10.1021/acs.analchem.4c00319.


Optical biosensors for diagnosis of COVID-19: nanomaterial-enabled particle strategies for post pandemic era.

Tekin Y, Kul S, Sagdic O, Rodthongkum N, Geiss B, Ozer T Mikrochim Acta. 2024; 191(6):320.

PMID: 38727849 PMC: 11087243. DOI: 10.1007/s00604-024-06373-6.


Development of rapid nucleic acid testing techniques for common respiratory infectious diseases in the Chinese population.

Zhi S, Wu W, Ding Y, Zhang Y, Pan L, Liu G Front Chem. 2024; 12:1381738.

PMID: 38694405 PMC: 11061412. DOI: 10.3389/fchem.2024.1381738.


Bioluminescent Intercalating Dyes for Ratiometric Nucleic Acid Detection.

de Stigter Y, van der Veer H, Rosier B, Merkx M ACS Chem Biol. 2024; 19(2):575-583.

PMID: 38315567 PMC: 10877566. DOI: 10.1021/acschembio.3c00755.


References
1.
Oh C, Sashittal P, Zhou A, Wang L, El-Kebir M, Nguyen T . Design of SARS-CoV-2 Variant-Specific PCR Assays Considering Regional and Temporal Characteristics. Appl Environ Microbiol. 2022; 88(7):e0228921. PMC: 9004361. DOI: 10.1128/aem.02289-21. View

2.
Azhar M, Phutela R, Kumar M, Ansari A, Rauthan R, Gulati S . Rapid and accurate nucleobase detection using FnCas9 and its application in COVID-19 diagnosis. Biosens Bioelectron. 2021; 183:113207. PMC: 8020606. DOI: 10.1016/j.bios.2021.113207. View

3.
Soares R, Akhtar A, Pinto I, Lapins N, Barrett D, Sandh G . Sample-to-answer COVID-19 nucleic acid testing using a low-cost centrifugal microfluidic platform with bead-based signal enhancement and smartphone read-out. Lab Chip. 2021; 21(15):2932-2944. DOI: 10.1039/d1lc00266j. View

4.
Kampf G, Lemmen S, Suchomel M . Ct values and infectivity of SARS-CoV-2 on surfaces. Lancet Infect Dis. 2020; 21(6):e141. PMC: 7832744. DOI: 10.1016/S1473-3099(20)30883-5. View

5.
Piepenburg O, Williams C, Stemple D, Armes N . DNA detection using recombination proteins. PLoS Biol. 2006; 4(7):e204. PMC: 1475771. DOI: 10.1371/journal.pbio.0040204. View